2-(3,4-Dihydroxyphenyl)-N-(prop-2-yn-1-yl)acetamide
95%
- Product Code: 41429
CAS:
1332585-62-2
| Molecular Weight: | 205.2099 g./mol | Molecular Formula: | C₁₁H₁₁NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD24620057 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its potential bioactive properties. It is often studied for its role as an intermediate in the synthesis of more complex molecules, particularly those targeting neurological disorders. The compound's structure, featuring a dihydroxyphenyl group, suggests potential antioxidant activity, making it relevant in research focused on oxidative stress-related conditions. Additionally, the presence of the propynyl group allows for further chemical modifications, enabling its use in the development of novel drugs or probes for biological studies. Its applications extend to the exploration of enzyme inhibition, particularly in pathways associated with neurodegenerative diseases, where it may serve as a scaffold for designing therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £43.76 |
+
-
|
2-(3,4-Dihydroxyphenyl)-N-(prop-2-yn-1-yl)acetamide
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its potential bioactive properties. It is often studied for its role as an intermediate in the synthesis of more complex molecules, particularly those targeting neurological disorders. The compound's structure, featuring a dihydroxyphenyl group, suggests potential antioxidant activity, making it relevant in research focused on oxidative stress-related conditions. Additionally, the presence of the propynyl group allows for further chemical modifications, enabling its use in the development of novel drugs or probes for biological studies. Its applications extend to the exploration of enzyme inhibition, particularly in pathways associated with neurodegenerative diseases, where it may serve as a scaffold for designing therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :